Your Cancer Game Plan Challenge
Behind the scenes on our first nutrition themed video with Hans Rueffert
A Future without Gastric Cancer
Gastric Cancer Foundation has no reviews yet.
Tell people what you think

Find the latest gastric cancer research updates and case studies, such as a 72-year-old man with previously treated metastatic gastric cancer who receives ramucirumab/paclitaxel, in this video from Research To Practice.

FLOT4-AIO: Results of a Phase III trial evaluating the effect of neoadjuvant chemotherapy followed by surgical resection on survival in patients with limited metastatic gastric or gastroesophageal junction (GEJ) carcinoma

Help those around you develop their “cancer game plan” by sharing Your Cancer Game Plan, a resource with videos, recipes, communication guides and more! Share the website here:

No automatic alt text available.

Do you know risk factors for gastric cancer? Using genomic technologies, a study published in Cell Press looks into the effects of having Helicobacter pylori infections and intestinal metaplasia on gastric cancer occurrence and progression.

Examining known risk factors for stomach cancer could lead to better ways to test for the disease.

You can be part of advancing critical research needed for a cure. Ask your physician how you can contribute to our Gastric Cancer Registry at the Stanford Cancer Institute.

Through the Gastric Cancer Registry, researchers gather significant data about people with stomach cancer that includes lifestyle, health and family histories, environmental factors as well

You can make an impact on the lives of someone affected by cancer – and help us continue providing support to our community. Visit, click our logo and share. For every share, Merck will donate $5 to our community.

It looks like you may be having problems playing this video. If so, please try restarting your browser.

Happy Valentine's Day. Thank you for having the heart to make a difference and advance research for a #StomachCancer cure!

No automatic alt text available.

Athenex, Inc. has released encouraging results in their recently completed Phase 1 clinical trial for Oraxol (oral paclitaxel) plus CYRAMZA® (ramucirumab) in gastric cancer patients who had failed previous chemotherapy treatments. Oraxol is an oral formulation of paclitaxel, a commonly used chemotherapy, combined with HM30181A (a novel P-gp inhibitor).

Athenex, Inc. (Nasdaq: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today...

Meet our newest Board Member, Arlene Weintraub Moskowitz, an award-winning journalist and author with 20 years of experience writing about healthcare, pharmaceuticals, and biotech. Arlene is committed to helping advance awareness and research for gastric cancer after losing her sister, a mother of four, to the disease earlier this decade. We’re lucky to have her expertise on board. Read her full bio here.

Image may contain: 1 person, smiling, child and closeup

These are just a few of the faces of those who have shared their advice on Your Cancer Game Plan. Help us tell their stories and support our mission. Learn how:

Image may contain: 11 people, people smiling, child, text and closeup

Although it's a long way from being a marketable device, researchers at Johns Hopkins Medicine Kimmel Cancer Center have developed a blood test (CancerSEEK) that screens and identified the location of certain cancer types, including gastric cancer.

Johns Hopkins Kimmel Cancer Center researchers developed a single blood test that screens for eight common cancer types and helps identify the location of the cancer.

You can help someone living with cancer with every share of Your Cancer Game Plan. It will also help us provide continued support and guidance to our community. Visit & click on our logo to start sharing.

It looks like you may be having problems playing this video. If so, please try restarting your browser.
Your Cancer Game Plan

Who is at risk and what can be done to prevent and treat gastric cancer?

A gastroenterologist discusses who is at risk and what can be done to prevent and treat stomach cancer.

Data shared at American Society of Clinical Oncology's Gastrointestinal Cancers Symposium also included research that found hyperthermic intraperitoneal chemotherapy (HIPEC), which delivers chemotherapy directly to cancer cells in the abdomen, increases survival for gastric cancer patients with peritoneal metastasis.

It’s #WorldCancerDay (and the big game)! We are proud to be on your team. Help support our mission by joining the Your Cancer Game Plan Challenge. Here’s how:

No automatic alt text available.
Gastric Cancer Foundation
Nonprofit Organization

Earlier detection for gastric cancer is becoming possible and attention is finally on our younger patients, whose incidence is increased. Read more in the American Society of Clinical Oncology roundup.

Dr. Vivian E. Strong and Dr. Ryan C. Fields discuss standards of care for varying stages of gastric cancer.